Cargando...
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
BACKGROUND: Benign prostatic hyperplasia (BPH) is a common condition in ageing men that may cause lower urinary tract symptoms (LUTS). Treatment aims are to relieve symptoms and prevent disease‐related complications. Naftopidil is an alpha‐blocker (AB) that has a high affinity for the A1d receptor t...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516835/ https://ncbi.nlm.nih.gov/pubmed/30306544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007360.pub3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|